http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19980703058-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate | 1996-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1998-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19980703058-A |
| titleOfInvention | Monthly injections useful as hormone replacement therapy and depot contraception for menopausal and premenopausal women |
| abstract | The present invention is directed to a monthly injection (once a month injectable drug) containing estrogen and gestagen as an active ingredient for the manufacture of pharmaceutical preparations for contraception and simultaneous hormone replacement therapy for women during and during menopause. It is about a use.n n n Using this pharmaceutical formulation, a more reliable contraceptive effect with natural estrogen (without ethynylestradiol) is obtained, with the accompanying active treatment of early estrogen loss symptoms and prevention of osteoporosis. |
| priorityDate | 1995-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.